PT688789E - Processo de lipopeptideos processo para a sua preparacao e sua utilizacao - Google Patents

Processo de lipopeptideos processo para a sua preparacao e sua utilizacao

Info

Publication number
PT688789E
PT688789E PT95104376T PT95104376T PT688789E PT 688789 E PT688789 E PT 688789E PT 95104376 T PT95104376 T PT 95104376T PT 95104376 T PT95104376 T PT 95104376T PT 688789 E PT688789 E PT 688789E
Authority
PT
Portugal
Prior art keywords
lipopeptide
preparing
lipopeptide derivatives
bacterial infections
pharmaceutical products
Prior art date
Application number
PT95104376T
Other languages
English (en)
Inventor
Peter Hammann
Rudolf Lattrell
Wollmann Dr Theodor
Wallmeier Dr Holger
Isert Dr Dieter
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of PT688789E publication Critical patent/PT688789E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT95104376T 1994-03-30 1995-03-24 Processo de lipopeptideos processo para a sua preparacao e sua utilizacao PT688789E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4411025A DE4411025A1 (de) 1994-03-30 1994-03-30 Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (1)

Publication Number Publication Date
PT688789E true PT688789E (pt) 2002-11-29

Family

ID=6514230

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95104376T PT688789E (pt) 1994-03-30 1995-03-24 Processo de lipopeptideos processo para a sua preparacao e sua utilizacao

Country Status (25)

Country Link
US (1) US5629288A (pt)
EP (1) EP0688789B1 (pt)
JP (1) JP3653119B2 (pt)
KR (1) KR100360129B1 (pt)
CN (1) CN1111640A (pt)
AT (1) ATE219499T1 (pt)
AU (1) AU696566B2 (pt)
CA (1) CA2145826C (pt)
CZ (1) CZ287158B6 (pt)
DE (2) DE4411025A1 (pt)
DK (1) DK0688789T3 (pt)
ES (1) ES2178657T3 (pt)
FI (1) FI951468A (pt)
HK (1) HK1012017A1 (pt)
HU (1) HU218286B (pt)
IL (1) IL113160A (pt)
MA (1) MA23490A1 (pt)
NO (1) NO951198L (pt)
NZ (1) NZ270828A (pt)
OA (1) OA10142A (pt)
PL (1) PL180274B1 (pt)
PT (1) PT688789E (pt)
RU (1) RU2141970C1 (pt)
TW (1) TW336939B (pt)
ZA (1) ZA952555B (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965524A (en) * 1989-07-07 1999-10-12 Peptide Technologies Corporation Analogs of viscosin and uses thereof
TW455591B (en) * 1993-06-08 2001-09-21 Hoechst Ag Lipopeptides from actinoplanes sp. with pharmacological action, process for their production and the use thereof
DE4411025A1 (de) * 1994-03-30 1995-10-05 Hoechst Ag Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
US6406880B1 (en) * 1997-05-02 2002-06-18 Integrated Research Technology, Llc Betaines as adjuvants to susceptibility testing and antimicrobial therapy
US7067500B2 (en) * 1997-05-02 2006-06-27 Integrated Research Technology, Llc Betaines as adjuvants to susceptibility testing and antimicrobial therapy
AU9464398A (en) * 1997-10-21 1999-05-10 Sankyo Company Limited Novel antifungal compounds
DE19807972A1 (de) * 1998-02-25 1999-08-26 Hoechst Marion Roussel De Gmbh Lipopeptidantibiotika-Calciumsalze, Verfahren zu ihrer Herstellung und Verwendung
WO2000063239A1 (fr) * 1999-04-16 2000-10-26 Sankyo Company, Limited Nouveaux composes antifongiques
US7408025B2 (en) * 1999-12-15 2008-08-05 Cubist Pharmaceuticals, Inc. Lipopeptides as antibacterial agents
US6911525B2 (en) 1999-12-15 2005-06-28 Cubist Pharmaceuticals, Inc. Lipopeptides as antibacterial agents
AU784942B2 (en) * 1999-12-15 2006-08-03 Cubist Pharmaceuticals, Inc. Daptomycin analogs and their use as antibacterial agents
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
US6511962B1 (en) * 2000-07-17 2003-01-28 Micrologix Biotech Inc. Derivatives of laspartomycin and preparation and use thereof
US6750199B2 (en) 2000-07-17 2004-06-15 Micrologix Biotech Inc. Antimicrobial sulfonamide derivatives of lipopeptide antibiotics
AU2001278933B2 (en) * 2000-07-17 2006-05-25 Migenix Inc. Antimicrobial sulfonamide derivatives of lipopeptide antibiotics
US6737403B2 (en) 2000-07-17 2004-05-18 Micrologix Biotech Inc. Derivatives of laspartomycin and preparation and use thereof
US20060014674A1 (en) * 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides
NZ571597A (en) 2000-12-18 2010-05-28 Cubist Pharm Inc Method for preparing crystalline and crystal-like forms of purified daptomycin lipopeptides
RU2348647C2 (ru) 2001-08-06 2009-03-10 Кьюбист Фармасьютикалз, Инк Новые депсипептиды и способы их получения
JP4402463B2 (ja) * 2002-01-03 2010-01-20 マイジェニックス インコーポレイテッド リポペプチド抗生物質のＤａｂ９誘導体およびそれを製造および使用する方法
CA2530063A1 (en) 2003-06-26 2005-01-06 Migenix Inc. Compositions of lipopeptide antibiotic derivatives and methods of use thereof
US8420602B2 (en) * 2004-09-14 2013-04-16 Landon C. G. Miller Endocannabinoid conjugate and a pharmaceutical composition for treatment of neuronal disorders
DE102005056194A1 (de) * 2005-11-21 2007-07-12 Combinature Biopharm Ag Neue Lipopeptid Zusammensetzungen
US7795207B2 (en) 2005-11-21 2010-09-14 Harald Labischinski Lipopeptide compositions
TWI409077B (zh) * 2006-04-18 2013-09-21 Piramal Life Sciences Ltd 新穎抗菌化合物
US7994791B2 (en) * 2007-02-19 2011-08-09 Schlumberger Technology Corporation Resistivity receiver spacing
GB0821540D0 (en) 2008-11-25 2008-12-31 Merlion Pharmaceuticals Pte Ltd Lipopeptide compounds and their use
RS53152B (en) * 2008-12-22 2014-06-30 Cubist Pharmaceuticals Inc. NEW ANTIBACTERIAL AGENTS FOR TREATMENT OF Gram POSITIVE INFECTIONS
HUE039967T2 (hu) 2009-11-23 2019-02-28 Cubist Pharmaceuticals Llc Lipopeptid kompozíció és ezzel kapcsolatos eljárások
CN103554230B (zh) * 2013-09-18 2015-07-22 福建省微生物研究所 一种安福霉素类化合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW455591B (en) * 1993-06-08 2001-09-21 Hoechst Ag Lipopeptides from actinoplanes sp. with pharmacological action, process for their production and the use thereof
DE4411025A1 (de) * 1994-03-30 1995-10-05 Hoechst Ag Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung

Also Published As

Publication number Publication date
PL307914A1 (en) 1995-10-02
EP0688789B1 (de) 2002-06-19
IL113160A (en) 1999-04-11
CN1111640A (zh) 1995-11-15
PL180274B1 (pl) 2001-01-31
RU95106362A (ru) 1996-12-27
OA10142A (fr) 1996-12-18
DE4411025A1 (de) 1995-10-05
IL113160A0 (en) 1995-06-29
KR100360129B1 (ko) 2003-03-26
CA2145826A1 (en) 1995-10-01
ES2178657T3 (es) 2003-01-01
KR950032636A (ko) 1995-12-22
AU696566B2 (en) 1998-09-10
DE59510246D1 (de) 2002-07-25
RU2141970C1 (ru) 1999-11-27
TW336939B (en) 1998-07-21
CZ77995A3 (en) 1995-10-18
NZ270828A (en) 1996-10-28
ATE219499T1 (de) 2002-07-15
US5629288A (en) 1997-05-13
HK1012017A1 (en) 1999-07-23
NO951198L (no) 1995-10-02
JPH07278186A (ja) 1995-10-24
HU218286B (en) 2000-07-28
FI951468A0 (fi) 1995-03-28
EP0688789A1 (de) 1995-12-27
FI951468A (fi) 1995-10-01
CZ287158B6 (en) 2000-10-11
MA23490A1 (fr) 1995-10-01
DK0688789T3 (da) 2002-10-14
AU1611095A (en) 1995-10-12
ZA952555B (en) 1995-12-21
NO951198D0 (no) 1995-03-29
CA2145826C (en) 2008-01-08
JP3653119B2 (ja) 2005-05-25
HUT71584A (en) 1995-12-28

Similar Documents

Publication Publication Date Title
PT688789E (pt) Processo de lipopeptideos processo para a sua preparacao e sua utilizacao
AU8772691A (en) New compounds
BR9611175B1 (pt) compostos e composiÇÕes farmacÊuticas.
MX9302214A (es) Derivados de taxol y proceso para su preparacion
BG101118A (en) Therapeutical compounds
AU2672995A (en) {a}-annelated pyrrole derivatives and pharmaceutical uses thereof
ES2097297T3 (es) Isoquinolein-5-il-sulfonamidas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
NO971625L (no) Nye peptider med immunomodulatoriske effekter
PT90592A (pt) Processo para a preparacao do antibiotico galidermina e de composicoes farmaceuticas e cosmeticas que o contem
ES2159733T3 (es) Compuestos de dialquiltiacumicina.
KR960703863A (ko) 암 치료용 신규 비스-나프탈이미드(New Bis-naphthalimides for the Treatment of Cancer)
PT98976A (pt) Processo para a preparacao de heteroarilmetilbenzenos
AU1929688A (en) Leukotriene antagonists, processes for the preparation thereof, the use thereof for the treatment of diseases, and precursors
DK0418990T3 (da) 13-brom- og 13,14-dibrom-ergoliner, deres fremstilling og anvendelse i lægemidler
AU7228094A (en) Substituted arylthioalkylthiopyridines
PT89582A (pt) Processo para a preparacao de antibioticos beta-lactamicos uteis como medicamentos
FI911616A0 (fi) Substituerade 3-tia- eller 3-oxa-alkyl -flavoner, foerfarande foer deras framstaellning, deras anvaendning, pao dessa foereningar baserade laekemedel samt mellanprodukter.
ATE207480T1 (de) Substituierte aminoalkylaminopyridine
PT874863E (pt) Derivados 3-desoxi-3-descladinose de eritromicinasa e b
PT93581A (pt) Processo para a preparacao de derivados cefalosporanicos e de composicoes farmaceuticas que os contem
PE64099A1 (es) Antibiotico derivado de cefalosporinas
AU8377691A (en) Use of N-(1-hexahydroazepinylalkyl)acetamides for the treatment of cholinergic transmission disorders